However, all 315 prostate cancer tissue samples from patients who underwent radical prostatectomy we examined were negative for ABCB1 expression, suggesting increased levels of ABCB1 expression occur as a resistance mechanism only after exposure to DTX. The gene discussed is ABCB1; the disease is Familial prostate cancer.